Literature DB >> 2578270

One-carbon metabolism in lectin-activated human lymphocytes.

P B Rowe, D Sauer, D Fahey, G Craig, E McCairns.   

Abstract

Serine is an essential amino acid for the lectin-mediated transformation of human peripheral blood lymphocytes due to the inability of this cell to synthesize sufficient quantities via either the phosphorylated pathway or by reversal of the serine hydroxymethyltransferase reaction to meet the metabolic demands. The level of intracellular serine is tightly regulated, and the culture medium concentration for optimum cellular transformation falls within a relatively narrow range. The three-carbon atom of serine is the major source of one-carbon units required for purine and pyrimidine nucleotide biosynthesis, but the key effect of both serine deprivation and of high medium serine levels would appear to be on protein synthesis. Although an alternative source of one-carbon units, as provided by high levels of formate in the culture medium, can partially reverse the effects of serine deprivation, the only other demonstrable source of one-carbon units, tryptophan, requires serine for its incorporation and subsequent metabolism. Methionine is also essential for lymphocyte transformation and is involved in the synthesis of a small amount of phosphatidylcholine, although most of this phospholipid is provided by choline and lysophosphatidylcholine from the serum-supplemented culture medium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578270     DOI: 10.1016/0003-9861(85)90627-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

Review 1.  Serine and one-carbon metabolism in cancer.

Authors:  Ming Yang; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture.

Authors:  K Snell; Y Natsumeda; G Weber
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

3.  Glucose contribution to nucleic acid base synthesis in proliferating hepatoma cells: a glycine-biosynthesis-mediated pathway.

Authors:  H Bismut; M Caron; C Coudray-Lucas; J Capeau
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

4.  Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs.

Authors:  J E Baggott; S L Morgan; T Ha; W H Vaughn; R J Hine
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

5.  Serine one-carbon catabolism with formate overflow.

Authors:  Johannes Meiser; Sergey Tumanov; Oliver Maddocks; Christiaan Fred Labuschagne; Dimitris Athineos; Niels Van Den Broek; Gillian M Mackay; Eyal Gottlieb; Karen Blyth; Karen Vousden; Jurre J Kamphorst; Alexei Vazquez
Journal:  Sci Adv       Date:  2016-10-28       Impact factor: 14.136

Review 6.  Formate metabolism in health and disease.

Authors:  Matthias Pietzke; Johannes Meiser; Alexei Vazquez
Journal:  Mol Metab       Date:  2019-07-30       Impact factor: 7.422

7.  Tracing Metabolic Fate of Mitochondrial Glycine Cleavage System Derived Formate In Vitro and In Vivo.

Authors:  Yee-Ling Tan; Nga-Lai Sou; Feng-Yao Tang; Hsin-An Ko; Wei-Ting Yeh; Jian-Hau Peng; En-Pei Isabel Chiang
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

8.  PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

Authors:  Annalisa D'Avola; Nathalie Legrave; Mylène Tajan; Probir Chakravarty; Ryan L Shearer; Hamish W King; Katarina Kluckova; Eric C Cheung; Andrew J Clear; Arief S Gunawan; Lingling Zhang; Louisa K James; James I MacRae; John G Gribben; Dinis P Calado; Karen H Vousden; John C Riches
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

9.  Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma.

Authors:  K Snell; Y Natsumeda; J N Eble; J L Glover; G Weber
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.